Country: Australia
Language: English
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
INSULIN
INTERVET AUSTRALIA PTY LIMITED
insulin(40IU/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
INSULIN HORMONE Active 40.0 IU/ml
1 x 10mL; 10 x 2.5mL
VM - Veterinary Medicine
INTERVET AUSTRALIA
CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
ENDOCRINE SYSTEM
INSULIN DEFICIENCY
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [INSULIN DEFICIENCY]; DOG: [INSULIN DEFICIENCY]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [INSULIN DEFICIENCY]; DOG: [INSULIN DEFICIENCY]; An intermediate acting insulin for the treatment of diabetes meilitus in dogs and cats.NOT TO BE USED in food producing species of animals. See RESTRAINTS & PRECAUTIONS on leaflet.
Registered
2023-07-01
REGISTERED PRODUCT NAME: CANINSULIN INSULIN FOR DOGS AND CATS PAGE 1 OF 2 PACK SIZES: 10ML, 2.5ML DATE (VERSION CONTROL): V3-02/10/2012 DESCRIPTION: VIAL LABEL TEXT APVMA: 37255/53781 PANEL LABELS, TEXT IN SQUARE BRACKETS AND ITALICS OR ABOVE THE HEADER AND BELOW THE FOOTER ARE NOT INCLUDED IN THIS LABEL TEXT. CLEAN COPY _MAIN PANEL (10 ML) _ PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CANINSULIN Insulin For Dogs And Cats ACTIVE CONSTITUENT: INSULIN 40 IU/mL An intermediate acting insulin for the treatment of diabetes mellitus in dogs and cats. 10 ML MSD LOGO _ _ _ANCILLIARY PANEL (10 ML) _ CANINSULIN Insulin For Dogs And Cats READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE: RESTRAINTS: NOT TO BE USED IN FOOD PRODUCING SPECIES OF ANIMALS. STORAGE: Store between 2 C and 8 C (Refrigerate. Do not freeze). Protect from light. Store upright. INTERVET AUSTRALIA PTY LIMITED (MSD Animal Health) 91-105 Harpin Street BENDIGO EAST VIC 3550 Phone: Customer Service 1800 033 461 APVMA Approval No.: 37255/53781 Batch No.: Expiry Date: RLP APPROVED Infopest Verified REGISTERED PRODUCT NAME: CANINSULIN INSULIN FOR DOGS AND CATS PAGE 2 OF 2 PACK SIZES: 10ML, 2.5ML DATE (VERSION CONTROL): V3-02/10/2012 DESCRIPTION: VIAL LABEL TEXT APVMA: 37255/53781 PANEL LABELS, TEXT IN SQUARE BRACKETS AND ITALICS OR ABOVE THE HEADER AND BELOW THE FOOTER ARE NOT INCLUDED IN THIS LABEL TEXT. CLEAN COPY _MAIN PANEL (2.5 ML) _ PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CANINSULIN Insulin For Dogs And Cats ACTIVE CONSTITUENT: INSULIN 40 IU/mL 2.5 ML MSD LOGO _ _ _ANCILLIARY PANEL (2.5 ML) _ CANINSULIN READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. STORAGE: Store between 2 C and 8 C (Refrigerate. Do not freeze). Protect from light. Store upright. APVMA Approval No.: 37255/53781 Batch No.: Expiry Date: REGISTERED PRODUCT NAME: CANINSULIN INSULIN FOR DOGS AND CATS PAGE 1 OF 2 PACK SIZES: 10 X 2.5ML, 1 X 10 ML DATE ( Read the complete document
PRODUCT NAME: CANINSULIN INSULIN FOR DOGS AND CATS MATERIAL SAFETY DATA SHEET THIS REVISION ISSUED: JULY, 2009 PAGE: 1 OF 5 MATERIAL SAFETY DATA SHEET Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461 (Business Hours) Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) SUBSTANCE: Insulin is a hormone. TRADE NAME: CANINSULIN INSULIN FOR DOGS AND CATS RECOMMENDED USE: Insulin injection for use in dogs and cats. APVMA NO: 37255 CREATION DATE: November, 2006 THIS VERSION ISSUED: July, 2009 and is valid for 5 years from this date. STATEMENT OF HAZARDOUS NATURE: THIS PRODUCT IS CLASSIFIED AS: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S20, S25, S45. When using, do not eat or drink. Avoid contact with eyes. In case of accident or if you feel unwell, contact a doctor or Poisons Information Centre immediately (show the label where possible). SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated PHYSICAL DESCRIPTION & COLOUR: White to off-white suspension. ODOUR: Characteristic odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. The most frequent complication is hypoglycaemia - symptoms include hunger, pallor, sweating, palpitations, anxiety, tremulousness, headache, double vision, slurred speech and numb mouth. If untreated convulsions and coma may ensue. Allergic reactions are also possible. INHALATION: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It should present no hazards in normal use. In addition product is unli Read the complete document